Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation.

Wei-Ru Chiou Chun-Che HuangPo-Lin LinJen-Yu ChuangLawrence Yu-Min LiuMin-I SuFeng-Ching LiaoChun-Yen ChenJen-Yuan KuoCheng-Ting TsaiYih-Jer WuYing-Hsiang Lee

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2020)

Concomitant use of rivaroxaban with AADs appears to be well tolerated, warranting further investigation into the apparent benefits of a reduced dose of rivaroxaban combined with dronedarone.

Keyphrases

atrial fibrillation
catheter ablation
venous thromboembolism
left atrial
oral anticoagulants
direct oral anticoagulants
left atrial appendage
pulmonary embolism
heart failure
randomized controlled trial
systematic review
magnetic resonance imaging
left ventricular
mitral valve